CYP3A4 and breast carcinoma: While an interaction between anastrozole and widely used chemotherapeutics in breast cancer patients such as cyclophosphamide, docetaxel, and paclitaxel is likely through inhibition of common metabolizer CYP3A4 [12, 31], our findings revealed no significant effects of previous chemotherapy on the basal level of anastrozole.